Product Batch	Antigen	Molecular Class	Drug Brand	Product Concentration	CoA	Quantity per vial	Storage Temperature	Expiry Date	Price from
Adalimumab 1909689A	TNF alpha	Biosimilar , Monoclonal Antibody	Hukyndra®	100 mg/mL	–	2 mg	-80°C	2023.10	309,60 €	view product Max: 10 Min: 1 Step: 1
Adalimumab 2LJPO1T11	TNF alpha	Biosimilar , Monoclonal Antibody	Yuflyma®	100 mg/mL	–	4 mg	-80°C	2024.02	309,60 €	view product Max: 10 Min: 1 Step: 1
Adalimumab 54371XH03	TNF alpha	Monoclonal Antibody	Humira®	100 mg/mL	yes	4 mg	-80°C	2025.05	438,00 €	view product Max: 10 Min: 1 Step: 1
Adalimumab 70225XH07	TNF alpha	Monoclonal Antibody	Humira®	100 mg/mL	yes	4 mg	-80°C	2018.09	591,30 €	view product Max: 4 Min: 1 Step: 1
Adalimumab 73254XH03	TNF alpha	Monoclonal Antibody	Humira®	100 mg/mL	yes	4 mg	-80°C	2018.12	591,30 €	view product Max: 10 Min: 1 Step: 1
Adalimumab 76287XH07	TNF alpha	Monoclonal Antibody	Humira®	100 mg/mL	yes	4 mg	-80°C	2019.03	591,30 €	view product Max: 10 Min: 1 Step: 1
Adalimumab 76287XH11	TNF alpha	Monoclonal Antibody	Humira®	100 mg/mL	yes	4 mg	-80°C	2019.03	591,30 €	view product Max: 10 Min: 1 Step: 1
Adalimumab 80315XH04	TNF alpha	Monoclonal Antibody	Humira®	100 mg/mL	yes	4 mg	-80°C	2019.07	591,30 €	view product Max: 9 Min: 1 Step: 1
Adalimumab AU034994	TNF alpha	Biosimilar , Monoclonal Antibody	Idacio®	50 mg/mL	–	2 mg	-80°C	2023.10	310,50 €	view product Max: 10 Min: 1 Step: 1
Adalimumab GR226512	TNF alpha	Biosimilar , Monoclonal Antibody	Imraldi®	50 mg/mL	–	2 mg	-80 °C	2023.10	265,50 €	view product Max: 10 Min: 1 Step: 1
Adalimumab MA8208	TNF alpha	Biosimilar , Monoclonal Antibody	Hyrimoz®	50 mg/mL	–	2 mg	-80°C	2024.06	265,50 €	view product Max: 10 Min: 1 Step: 1
Infliximab	TNF alpha	Biosimilar , Monoclonal Antibody	Remsima®	10 mg/mL	–	3 mg	tba	tba	233,00 €	view product Max: 20 Min: 10 Step: 1
Infliximab EC1216	TNF alpha	Biosimilar , Monoclonal Antibody	Flixabi®	10 mg/mL	–	2 mg	-80°C	2025.01	232,00 €	view product Max: 10 Min: 2 Step: 1
Infliximab GF5988	TNF alpha	Biosimilar , Monoclonal Antibody	Inflectra®	10 mg/mL	–	2 mg	- 80°C	2027.03	233,00 €	view product Max: 10 Min: 2 Step: 1
Ustekinumab GKS1LMO	IL-12	Monoclonal Antibody	Stelara®	90 mg/mL	–	4 mg	-80°C	2018.10	1.005,30 €	view product Max: 10 Min: 1 Step: 1
Ustekinumab HCS1YMQ	IL-12	Monoclonal Antibody	Stelara®	90 mg/mL	–	4 mg	-80°C	2019.02	1.005,30 €	view product Max: 10 Min: 1 Step: 1
Ustekinumab HES3CMC	IL-12	Monoclonal Antibody	Stelara®	90 mg/mL	–	4 mg	-80°C	2019.05	1.005,30 €	view product Max: 10 Min: 1 Step: 1
Ustekinumab HIS2WMB	IL-12	Monoclonal Antibody	Stelara®	90 mg/mL	–	4 mg	-80°C	2019.08	1.005,30 €	view product Max: 10 Min: 1 Step: 1
Ustekinumab IAS1GMF.A	IL-12	Monoclonal Antibody	Stelara®	90 mg/mL	–	4 mg	-80°C	2019.12	1.005,30 €	view product Max: 10 Min: 1 Step: 1
Ustekinumab IDS2MMF	IL-12	Monoclonal Antibody	Stelara®	90 mg/mL	–	4 mg	-80°C	2021.04	1.005,30 €	view product Max: 2 Min: 1 Step: 1
Ustekinumab MKS17MB	IL-12	Monoclonal Antibody	Stelara®	90 mg/mL	–	4 mg	-80°C	2025.10	1.117,00 €	view product Max: 2 Min: 1 Step: 1
Vedolizumab 12371750	alpha 4 beta 7 integrin	Monoclonal Antibody	Entyvio®	158,8 mg/mL	–	4 mg	-80°C	2024.06	292,50 €	view product Max: 5 Min: 1 Step: 1
Vedolizumab 12741490	alpha 4 beta 7 integrin	Monoclonal Antibody	Entyvio®	158,8 mg/mL	–	4 mg	-80°C	2025.12	325,00 €	view product Max: 10 Min: 1 Step: 1

Crohn's Disease

Crohn’s disease is a chronic relapsing, remitting inflammatory disease of the gastrointestinal tract, the cause of which is unknown. This disease can affect all the gastrointestinal tract discontinuously. Some patients may have continuous clinically active disease.

Not looking for Crohn's Disease?

Search our therapeutic molecules product database